Form 483

Allergan Pharmaceuticals Ireland Form 483, 2016-12-16

FDA issued a Form 483 to Allergan Pharmaceuticals Ireland on 2016-12-16 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Allergan Pharmaceuticals Ireland · Westport, Ireland · Issued December 16, 2016

Overview

  • 6 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Dec 2016
21 CFR 211.192

Quality control unit review of records

Cited by Marcus F Yambot

16 Dec 2016
21 CFR 211.42(c)(10)(iii)

Air Supply

Cited by Marcus F Yambot

16 Dec 2016
21 CFR 211.192

Quality control unit review of records

Cited by Marcus F Yambot

16 Dec 2016
21 CFR 211.42(c)(10)(iii)

Air Supply

Cited by Marcus F Yambot

16 Dec 2016
21 CFR 211.192

Quality control unit review of records

Cited by Marcus F Yambot

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations3x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations3x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere